Researcher Profile Statistics: Maha Reda Elsyed
Geo Map
Region
#
AF - Africa
4
AS - Asia, other
3
EU - Europe
3
NA - North America
1
Unknown
18
Total
29
Country
#
EG - Egypt
4
CN - China
3
FI - Finland
2
DE - Germany
1
US - United States of America
1
Unknown
18
Total
29
City
#
Al Fayyum
3
Hefei
1
Jacksonville
1
Nanjing
1
Unknown
23
Total
29
Most viewed items
#
ID: 3910 - Interaction of Coenzyme Q10 with Liposomes and its Impact on Suppression of Selenite – Induced Experimental Cataract
29
Total
29
Most type viewed
#
ID: all -
29
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
29
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
1 1 0 0
0 0
2
2020
3 0
2 0 0 0
0 0 0 0
0 0
5
2021
0 0
1 0 1 0
0 2 0 0
0 1
5
2022
0 0
2 0 0 0
0 0 0 3
0 0
5
2023
0 0
1 0 2 0
0 0 1 0
1 0
5
2024
1 0
1 0 2 0
0 0 0 0
0 0
4
Ever
29
Geo Map
Region | # |
---|---|
AF - Africa | 4 |
AS - Asia, other | 3 |
EU - Europe | 3 |
NA - North America | 1 |
Unknown | 18 |
Total | 29 |
Country | # |
---|---|
EG - Egypt | 4 |
CN - China | 3 |
FI - Finland | 2 |
DE - Germany | 1 |
US - United States of America | 1 |
Unknown | 18 |
Total | 29 |
City | # |
---|---|
Al Fayyum | 3 |
Hefei | 1 |
Jacksonville | 1 |
Nanjing | 1 |
Unknown | 23 |
Total | 29 |
Most viewed items | # |
---|---|
ID: 3910 - Interaction of Coenzyme Q10 with Liposomes and its Impact on Suppression of Selenite – Induced Experimental Cataract | 29 |
Total | 29 |
Most type viewed | # |
---|---|
ID: all - | 29 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 29 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
2020 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
2021 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 5 |
2022 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 5 |
2023 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 5 |
2024 | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Ever | 29 |